"O Hospital Garcia de Orta, é uma pessoa coletiva de direito público de natureza empresarial dotada de autonomia administrativa, financeira e patrimonial. O HGO serve atualmente uma população estimada em cerca de 350 mil habitantes dos concelhos de Almada e Seixal, sendo que em algumas valências a sua zona de influência extravasa largamente estes dois concelhos, estendendo-se a toda a Península de Setúbal, nomeadamente nas áreas de especialidade de Neonatologia e Neurocirurgia. O HGO dispõe de uma lotação de 545 camas, distribuídas por várias especialidades e serviços de referência que apoiam regularmente outros hospitais. O Hospital conta atualmente com cerca de 2500 funcionários."

During the past decade, Hospital Garcia de Orta conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 21 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 16 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Garcia de Orta" #1 sponsor was "Boehringer Ingelheim" with 9 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Amgen" with 4 trials sponsored, "Bayer" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Garcia de Orta" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Andalusian Network for Design and Translation of Advanced Therapies" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene, Ltd." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Garcia de Orta" are "Atrial Fibrillation" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "PAH" (3 trials), "Cardiovascular Diseases" (2 trials) and "Connective Tissue Diseases" (2 trials). Many other conditions were trialed in "Hospital Garcia de Orta" in a lesser frequency.

Most popular intervention types in "Hospital Garcia de Orta" are "Drug" (54 trials), "Device" (8 trials), "Biological" (4 trials), "Diagnostic Test" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Cisplatin" (4 trials), "Gemcitabine" (3 trials), "Nintedanib" (3 trials) and "Cetrelimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Garcia de Orta" are 67 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Garcia de Orta". undefined are not yet recruiting, 21 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Hospital Garcia de Orta, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Garcia de Orta, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".